These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30350867)

  • 1. Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas.
    Dietz S; Lifshitz A; Kazdal D; Harms A; Endris V; Winter H; Stenzinger A; Warth A; Sill M; Tanay A; Sültmann H
    Int J Cancer; 2019 Mar; 144(5):1061-1072. PubMed ID: 30350867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation intratumor heterogeneity in localized lung adenocarcinomas.
    Quek K; Li J; Estecio M; Zhang J; Fujimoto J; Roarty E; Little L; Chow CW; Song X; Behrens C; Chen T; William WN; Swisher S; Heymach J; Wistuba I; Zhang J; Futreal A; Zhang J
    Oncotarget; 2017 Mar; 8(13):21994-22002. PubMed ID: 28423542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.
    Hua X; Zhao W; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Zhu B; Wang M; Jones K; Hicks B; Song L; Sampson J; Wedge DC; Shi J; Landi MT
    Nat Commun; 2020 May; 11(1):2459. PubMed ID: 32424208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.
    Brocks D; Assenov Y; Minner S; Bogatyrova O; Simon R; Koop C; Oakes C; Zucknick M; Lipka DB; Weischenfeldt J; Feuerbach L; Cowper-Sal Lari R; Lupien M; Brors B; Korbel J; Schlomm T; Tanay A; Sauter G; Gerhäuser C; Plass C;
    Cell Rep; 2014 Aug; 8(3):798-806. PubMed ID: 25066126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts.
    Kazdal D; Endris V; Allgäuer M; Kriegsmann M; Leichsenring J; Volckmar AL; Harms A; Kirchner M; Kriegsmann K; Neumann O; Brandt R; Talla SB; Rempel E; Ploeger C; von Winterfeld M; Christopoulos P; Merino DM; Stewart M; Allen J; Bischoff H; Meister M; Muley T; Herth F; Penzel R; Warth A; Winter H; Fröhling S; Peters S; Swanton C; Thomas M; Schirmacher P; Budczies J; Stenzinger A
    J Thorac Oncol; 2019 Nov; 14(11):1935-1947. PubMed ID: 31349062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclonal evolution of pulmonary adenocarcinomas delineated by spatially distributed somatic mitochondrial mutations.
    Kazdal D; Harms A; Endris V; Penzel R; Oliveira C; Kriegsmann M; Longuespée R; Winter H; Schneider MA; Muley T; Pfarr N; Weichert W; Stenzinger A; Warth A
    Lung Cancer; 2018 Dec; 126():80-88. PubMed ID: 30527196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas.
    Hu X; Estecio MR; Chen R; Reuben A; Wang L; Fujimoto J; Carrot-Zhang J; McGranahan N; Ying L; Fukuoka J; Chow CW; Pham HHN; Godoy MCB; Carter BW; Behrens C; Zhang J; Antonoff MB; Sepesi B; Lu Y; Pass HI; Kadara H; Scheet P; Vaporciyan AA; Heymach JV; Wistuba II; Lee JJ; Futreal PA; Su D; Issa JJ; Zhang J
    Nat Commun; 2021 Jan; 12(1):687. PubMed ID: 33514726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow-sorting approach.
    Lorber T; Andor N; Dietsche T; Perrina V; Juskevicius D; Pereira K; Greer SU; Krause A; Müller DC; Savic Prince S; Lardinois D; Barrett MT; Ruiz C; Bubendorf L
    J Pathol; 2019 Feb; 247(2):199-213. PubMed ID: 30350422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas.
    Dietz S; Harms A; Endris V; Eichhorn F; Kriegsmann M; Longuespée R; Stenzinger A; Sültmann H; Warth A; Kazdal D
    Int J Cancer; 2017 Nov; 141(9):1841-1848. PubMed ID: 28699162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
    Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
    Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
    Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
    Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Underpinnings of Tumor Behavior in
    Qian J; Zhao S; Zou Y; Rahman SMJ; Senosain MF; Stricker T; Chen H; Powell CA; Borczuk AC; Massion PP
    Am J Respir Crit Care Med; 2020 Mar; 201(6):697-706. PubMed ID: 31747302
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine.
    Röcken C; Amallraja A; Halske C; Opasic L; Traulsen A; Behrens HM; Krüger S; Liu A; Haag J; Egberts JH; Rosenstiel P; Meißner T
    Genome Med; 2021 Nov; 13(1):177. PubMed ID: 34749812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression.
    Tavernari D; Battistello E; Dheilly E; Petruzzella AS; Mina M; Sordet-Dessimoz J; Peters S; Krueger T; Gfeller D; Riggi N; Oricchio E; Letovanec I; Ciriello G
    Cancer Discov; 2021 Jun; 11(6):1490-1507. PubMed ID: 33563664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking the Evolution of Non-Small-Cell Lung Cancer.
    Jamal-Hanjani M; Wilson GA; McGranahan N; Birkbak NJ; Watkins TBK; Veeriah S; Shafi S; Johnson DH; Mitter R; Rosenthal R; Salm M; Horswell S; Escudero M; Matthews N; Rowan A; Chambers T; Moore DA; Turajlic S; Xu H; Lee SM; Forster MD; Ahmad T; Hiley CT; Abbosh C; Falzon M; Borg E; Marafioti T; Lawrence D; Hayward M; Kolvekar S; Panagiotopoulos N; Janes SM; Thakrar R; Ahmed A; Blackhall F; Summers Y; Shah R; Joseph L; Quinn AM; Crosbie PA; Naidu B; Middleton G; Langman G; Trotter S; Nicolson M; Remmen H; Kerr K; Chetty M; Gomersall L; Fennell DA; Nakas A; Rathinam S; Anand G; Khan S; Russell P; Ezhil V; Ismail B; Irvin-Sellers M; Prakash V; Lester JF; Kornaszewska M; Attanoos R; Adams H; Davies H; Dentro S; Taniere P; O'Sullivan B; Lowe HL; Hartley JA; Iles N; Bell H; Ngai Y; Shaw JA; Herrero J; Szallasi Z; Schwarz RF; Stewart A; Quezada SA; Le Quesne J; Van Loo P; Dive C; Hackshaw A; Swanton C;
    N Engl J Med; 2017 Jun; 376(22):2109-2121. PubMed ID: 28445112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
    Torres L; Ribeiro FR; Pandis N; Andersen JA; Heim S; Teixeira MR
    Breast Cancer Res Treat; 2007 Apr; 102(2):143-55. PubMed ID: 16906480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
    Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPA.
    Moelans CB; de Groot JS; Pan X; van der Wall E; van Diest PJ
    Mod Pathol; 2014 Jun; 27(6):869-74. PubMed ID: 24287456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.
    Zito Marino F; Liguori G; Aquino G; La Mantia E; Bosari S; Ferrero S; Rosso L; Gaudioso G; De Rosa N; Scrima M; Martucci N; La Rocca A; Normanno N; Morabito A; Rocco G; Botti G; Franco R
    PLoS One; 2015; 10(9):e0139264. PubMed ID: 26422230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
    Dötsch MM; Kloten V; Schlensog M; Heide T; Braunschweig T; Veeck J; Petersen I; Knüchel R; Dahl E
    Epigenetics; 2015; 10(10):903-12. PubMed ID: 26252352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.